Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin gel and PRGF for class II furcation involvement
IRCT20100427003813N7Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atorvastatin and PRGF-Endoret in chronic periodontitis and Furcation defect (4 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Vertical probing depth, Vertical clinical attachment level and 3 more. Started May 2017; status: completed.
02
Drugs
atorvastatinPRGF-Endoret
03
Conditions
chronic periodontitisFurcation defect
Beyond the preview
Go deeper on IRCT20100427003813N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100427003813N7.